GABA and its receptors in the spinal cord

Trends in Pharmacological Sciences

Volumn 17, Issue 12, 1996, Pages 457-462

  Malcangio, Marzia ^a   Bowery, Norman G ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BACLOFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN; CONTROLLED STUDY; MUSCLE RELAXATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; REVIEW; SPINAL CORD;

EID: 0030459624     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(96)01013-9     Document Type: Review

References (59)

1. 1 Smith, G. B. and Olsen, R. W. (1995) Trends Pharmacol. Sci. 16, 162-168
2. 2 Bohlhalter, S., Weinmann, O., Mohler, H. and Fritschy, J-M. (1996) J. Neurosci. 16, 283-297
3. 3 Bowery, N. G. (1993) Annu. Rev. Pharmacol. Toxicol. 33, 109-147
4. 4 Johnston, G. A. R. (1996) Trends Pharmacol. Sci. 17, 319-323
5. 5 Kanner, B. I. (1996) in GABA: Receptors, Transporters and Metabolism (Tanaka, C. and Bowery, N. G., eds), pp. 53-61, Birkhäuser
6. 6 Lin, H. et al. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1009-1013
7. 7 Szabat, E., Soinila, S., Happola, O., Linnala, A. and Virtanen, I. (1992) Neuroscience 47, 409-420
8. 8 Sakamoto, H. and Atsumi, S. (1995) Neurosci. Res. 23, 335-343
9. 9 Alvarez, F. J., Kavookjian, A. M. and Light A. R. (1992) J. Neurosci. 12, 2901-2917
10. 10 Price, G. W., Wilkin, G. P., Turnbull, M. J. and Bowery, N. G. (1984) Nature 307, 71-74
11. 11 Sakatani, K., Chesler, M. and Hassan, A. Z. (1991) Brain Res. 542, 273-279
12. 12 Roberts, E. (1974) Biochem. Pharmacol. 23, 2637-2649
13. 13 Yoshimura, M. and Nishi, S. (1995) J. Physiol. 482, 29-38
14. 14 Curtis, D. R., Gynther, B. D. and Malik, K. R. (1986) Exp. Brain Res. 64, 105-113
15. 15 Curtis, D. R., Lodge, D. and Bornstein, J. C. (1981) Exp. Brain Res. 42, 158-170
16. 16 Teoh, H., Malcangio, M. and Bowery, N. G. (1996) Br. J. Pharmacol. 118, 1153-1160
17. 17 Kangrga, I., Jang, M. and Randic, M. (1991) Brain Res. 562, 265-275
18. 18 Go, L. W. and Yaksh, T. L. (1987) J. Physiol. 391, 141-167
19. 19 Malcangio, M. and Bowery, N. G. (1993) J. Pharmacol. Exp. Ther. 266, 1490-1496
20. 20 Bourgoin, S. et al. (1992) Brain Res. 583, 344-348
21. 21 Sawynok, J., Kato, N., Havlicek, V. and LaBella, F.S. (1982) Naunyn-Schmiedeberg's Arch. Pharmacol. 319, 78-81
22. 22 Morton, C. R., Hutchison, W. D. and Lacey, G. (1992) Eur. J. Neurosci. 4, 243-250
23. 23 Malcangio, M. and Bowery, N. G. (1995) Clin. Neuropharmacol. 18, 285-305
24. 24 Santicioli, P., Del Bianco, E., Tramontana, M. and Maggi, C. A. (1992) Neurosci. Lett. 144, 211-214
25. 25 Curtis, D. R., Wilson, V. and Malik, R. (1984) Brain Res. 295, 372-375
26. 26 Curtis, D. R . and Malik, R. (1985) Exp. Brain Res. 58, 333-337
27. 27 Curtis, D. R. and Lacey, G. (1994) NeuroReport 5, 540-542
28. 28 Henry, J. L. (1982) Neuropharmacology 21, 1085-1093
29. 29 Polc, P., Mohler, H. and Haefely, W. (1974) Naunyn-Schmiedeberg's Arch. Pharmacol. 284, 319-337
30. 30 Siarey, R. J., Long, S. K., Tulp, M. T. H. and Evans, R. H. (1994) Br. J. Pharmacol. 111, 497-502
31. 31 Kato, M., Waldmann, U. and Murakami, S. (1978) Neuropharmacology 17, 827-833
32. 32 Lacey, G. and Curtis, D. R. (1994) Exp. Brain Res. 101, 59-72
33. 33 Brogden, R. N., Speight, T. M. and Avery, G. S. (1974) Drugs 8, 1-14
34. 34 Penn, R. D. and Kroin, J. S. (1984) Lancet 1, 1078
35. 35 Malcangio, M., Libri, V., Teoh, H., Constanti, A. and Bowery, N. G. (1995) NeuroReport 6, 399-403
36. 36 Sawynok, J. (1987) Pharmacol. Biochem. Behav. 26, 463-474
37. 37 Hammond, D. L. and Washington, J. D. (1993) Eur. J. Pharmacol. 234, 255-262
38. 38 Hao, J-H., Xiao-Jun, X. and Wiesenfeld-Hallin, Z. (1994) Neurosci. Lett. 182, 299-302
39. 39 Yaksh, T. L. (1989) Pain 37, 111-123
40. 40 Gowan, M. K. and Hammond, D. L. (1993) Brain Res. 607, 39-46
41. 41 Lin, Q., Peng, Y. B. and Willis, W. D. (1996) J. Neurophysiol. 75, 109-123
42. 42 Gordon, N. C. et al. (1995) Neuroscience 69, 345-349
43. 43 Melzack, R. and Wall, P. D. (1965) Science 150, 971-979
44. 44 Littlewood, N. K., Todd, A. J., Spike, R. C., Watt, C. and Shehab, S. A. S. (1995) Neuroscience 66, 597-608
45. 45 Hayes, E. S. and Carlton, S. M. (1992) Neuroscience 47, 873-896
46. 46 Bernardi, P. S., Valtschanoff, J. G., Weinberg, R. J., Schmidt, H. H. H. W. and Rustioni, A. (1995) J. Neurosci. 15, 1363-1371
47. 47 Haley, J. E., Sullivan, A. F. and Dickenson, A. H. (1990) Brain Res. 518, 212-226
48. 48 Mendell, L. M. and Wall, P. D. (1965) Nature 206, 97-99
49. 49 Castro-Lopes, J. M., Tavares, I., Tolle, T. R., Coito, A. and Coimbra, A. (1992) Eur. J. Neurosci. 4, 296-301
50. 50 Nahin, R. L. and Hylden, K. K. (1991) Neurosci. Lett. 128, 226-230
51. 51 Castro-Lopes, J. M., Tolle, T. R., Pan, B. and Zieglgansberger, W. (1994) Mol. Brain Res. 26, 169-176
52. 52 Malcangio, M. and Bowery, N. G. (1994) Br. J. Pharmacol. 113, 1561-1566
53. 53 Malcangio, M., Ghelardini, C., Giotti, A., Malmberg-Aiello, P. and Bartolini, A. (1991) Br. J. Pharmacol. 103, 1303-1308
54. 54 Malcangio, M., Malmberg-Aiello, P., Giotti, A., Ghelardini, C. and Bartolini, A. (1992) Neuropharmacology 31, 783-791
55. 55 Malcangio, M. and Bowery, N. G. (1996) Pain 66, 351-358
56. 56 Castro-Lopes, J. M., Malcangio, M., Pan, B. H. and Bowery, N. G. (1995) Brain Res. 679, 289-297
57. 57 Castro-Lopes, J. M., Tavares, I. and Coimbra, A. (1993) Brain Res. 620, 287-291
58. 58 Smith, G. D. et al. (1994) Neuropharmacology 33, 1103-1108
59. 59 Kingery, W. S., Fields, R. D. and Kocsis, J. D. (1988) Exp. Neurol. 100, 478-490